A 24-year-old woman complains of intermittent fever and joint pain. She says that these symptoms have been present for the past month. Before that, she had no signs or symptoms and was completely healthy. She has also lost her appetite and some weight. A complete blood count (CBC) showed severe pancytopenia. What is the next best step in evaluating this patient?
Q2
A 32-year-old man is brought to the emergency department by the police for examination. The police have reason to believe he may have swallowed a large number of cocaine-containing capsules during an attempt to smuggle the drug across the border. They request an examination of the patient to determine if this is actually the case. The patient has no history of any serious illnesses and takes no medications. He does not smoke, drinks, or consume any drugs. He appears upset. His vital signs are within normal limits. Despite the pressure by the police, he refuses to undergo any further medical evaluation. Which of the following is the most appropriate next step in the evaluation of this patient?
Q3
A 28-year-old woman dies shortly after receiving a blood transfusion. Autopsy reveals widespread intravascular hemolysis and acute renal failure. Investigation reveals that she received type A blood, but her medical record indicates she was type O. In a malpractice lawsuit, which of the following elements must be proven?
Q4
A research group wants to assess the safety and toxicity profile of a new drug. A clinical trial is conducted with 20 volunteers to estimate the maximum tolerated dose and monitor the apparent toxicity of the drug. The study design is best described as which of the following phases of a clinical trial?
Q5
A 65-year-old woman presents to her primary care physician for a wellness checkup. She states that she has felt well lately and has no concerns. The patient has a 12-pack-year smoking history and has 3 drinks per week. She is retired and lives at home with her husband. She had a normal colonoscopy 8 years ago and mammography 1 year ago. She can't recall when she last had a Pap smear and believes that it was when she was 62 years of age. Her temperature is 98.1°F (36.7°C), blood pressure is 137/78 mmHg, pulse is 80/min, respirations are 13/min, and oxygen saturation is 98% on room air. Physical exam is within normal limits. Which of the following is the best next step in management?
Q6
A 78-year-old woman is brought to the emergency ward by her son for lethargy and generalized weakness. The patient speaks in short utterances and does not make eye contact with the provider or her son throughout the interview and examination. You elicit that the patient lives with her son and daughter-in-law, and she reports vague weakness for the last couple days. The emergency room provider notices 3-4 healing bruises on the patient's upper extremities; otherwise, examination is not revealing. Routine chemistries and blood counts are unremarkable; non-contrast head CT demonstrates normal age-related changes. Which of the following is the most appropriate next step in management?
Q7
A 59-year-old woman comes to the physician because of left leg swelling that started after a transcontinental flight. A duplex ultrasound of the left leg shows a noncompressible popliteal vein. A drug is prescribed that inhibits the coagulation cascade. Two weeks later, laboratory studies show:
Platelet count 210,000/mm3
Partial thromboplastin time 28 seconds (normal: 25-35)
Prothrombin time 12 seconds (normal: 11-13)
Thrombin time 15 seconds (control: 15 seconds)
Which of the following drugs was most likely prescribed?
Case closure timing US Medical PG Practice Questions and MCQs
Question 1: A 24-year-old woman complains of intermittent fever and joint pain. She says that these symptoms have been present for the past month. Before that, she had no signs or symptoms and was completely healthy. She has also lost her appetite and some weight. A complete blood count (CBC) showed severe pancytopenia. What is the next best step in evaluating this patient?
A. Repeated CBCs for several weeks and reassess
B. Treatment with corticosteroids
C. Treatment with antibiotics
D. Treatment for acute leukemia
E. Bone marrow examination (Correct Answer)
Explanation: ***Bone marrow examination***
- The combination of **fever**, **joint pain**, **weight loss**, and **pancytopenia** in a previously healthy young woman raises suspicion for serious hematologic conditions like **aplastic anemia** or **acute leukemia**.
- A **bone marrow examination** is crucial for definitive diagnosis by evaluating the cellularity, morphology, and presence of abnormal cells.
*Repeated CBCs for several weeks and reassess*
- This approach is inappropriate given the **severe pancytopenia** and progressive symptoms, which indicate an urgent underlying pathology.
- Delaying diagnosis could worsen the patient's condition and compromise treatment outcomes due to the potential for severe infections or bleeding.
*Treatment with corticosteroids*
- While corticosteroids might be used in some autoimmune conditions causing pancytopenia, initiating treatment without a definitive diagnosis is premature and could mask the underlying cause, especially in cases of malignancy.
- There is no specific indication for corticosteroid use in this scenario without further diagnostic information.
*Treatment with antibiotics*
- Although **fever** is present, there's no clear evidence of an infection (like localized symptoms or positive cultures), and **pancytopenia** is not primarily managed with antibiotics.
- Administering antibiotics empirically without a confirmed infection addresses a symptom rather than the underlying progressive hematological disorder.
*Treatment for acute leukemia*
- While **acute leukemia** is a strong possibility, definitive treatment should only commence after a confirmed diagnosis through **bone marrow examination**, as misdiagnosis can lead to inappropriate and harmful therapy.
- Other conditions like severe aplastic anemia also present with similar features but require different management strategies.
Question 2: A 32-year-old man is brought to the emergency department by the police for examination. The police have reason to believe he may have swallowed a large number of cocaine-containing capsules during an attempt to smuggle the drug across the border. They request an examination of the patient to determine if this is actually the case. The patient has no history of any serious illnesses and takes no medications. He does not smoke, drinks, or consume any drugs. He appears upset. His vital signs are within normal limits. Despite the pressure by the police, he refuses to undergo any further medical evaluation. Which of the following is the most appropriate next step in the evaluation of this patient?
A. Examine the patient without his consent
B. Request a court order from the police
C. Obtain an abdominal X-ray
D. Refuse to examine the patient
E. Explain the risk of internal rupture to the patient (Correct Answer)
Explanation: ***Explain the risk of internal rupture to the patient***
- The primary responsibility of the physician is to the **patient's well-being**, not to law enforcement. Before any action, the patient must be fully informed of the **potential life-threatening risks**, such as capsule rupture and overdose, associated with concealing drugs internally, especially if they are asymptomatic.
- This approach respects the patient's **autonomy** while ensuring they understand the gravity of their situation, potentially motivating them to reconsider their refusal for medical evaluation for their own safety.
*Examine the patient without his consent*
- Examining an **adult patient without their consent** is a violation of ethical principles and could constitute **assault and battery**, regardless of police requests or suspected criminal activity.
- The patient's **competence** to refuse care is not questioned, and there is no immediate indication of a medical emergency that would override his refusal, as his vital signs are stable and he is not in distress.
*Request a court order from the police*
- While a court order might compel some medical procedures in specific legal contexts, it generally does not override a competent patient's right to refuse medical care, especially when they are **asymptomatic** and not in immediate danger.
- The physician's immediate ethical duty is to the patient's health and safety, not to facilitate legal processes that could infringe on patient rights without clear medical necessity.
*Obtain an abdominal X-ray*
- An abdominal X-ray is a medical procedure that requires patient consent. Performing it without consent would be a breach of **medical ethics** and patient rights, even if requested by police.
- Although an X-ray could confirm the presence of foreign objects, it should not be performed before **informed consent** is obtained or before the patient understands the potential risks they face due to the suspected objects.
*Refuse to examine the patient*
- While the patient initially refused examination, simply refusing to examine him at all would be negligent as it indicates a failure to address the potential medical emergency presented by suspected internal drug smuggling.
- The physician has a duty to at least **educate the patient** about the severe health risks involved, allowing him to make an informed decision about further medical evaluation.
Question 3: A 28-year-old woman dies shortly after receiving a blood transfusion. Autopsy reveals widespread intravascular hemolysis and acute renal failure. Investigation reveals that she received type A blood, but her medical record indicates she was type O. In a malpractice lawsuit, which of the following elements must be proven?
A. Duty, breach, causation, and damages (Correct Answer)
B. Only duty and breach
C. Only breach and causation
D. Duty, breach, and damages
Explanation: ***Duty, breach, causation, and damages***
- In a medical malpractice lawsuit, all four elements—**duty, breach, causation, and damages**—must be proven for a successful claim.
- The healthcare provider had a **duty** to provide competent care, they **breached** that duty by administering the wrong blood type, this breach **caused** the patient's death and renal failure, and these injuries constitute **damages**.
*Only duty and breach*
- While **duty** and **breach** are necessary components, proving only these two is insufficient for a malpractice claim.
- It must also be demonstrated that the breach directly led to the patient's harm and resulted in legally recognized damages.
*Only breach and causation*
- This option omits the crucial elements of professional **duty** owed to the patient and the resulting **damages**.
- A claim cannot succeed without establishing that a duty existed and that quantifiable harm occurred.
*Duty, breach, and damages*
- This option misses the critical element of **causation**, which links the provider's breach of duty to the patient's injuries.
- Without proving that the breach *caused* the damages, even if a duty was owed and breached, and damages occurred, the claim would fail.
Question 4: A research group wants to assess the safety and toxicity profile of a new drug. A clinical trial is conducted with 20 volunteers to estimate the maximum tolerated dose and monitor the apparent toxicity of the drug. The study design is best described as which of the following phases of a clinical trial?
A. Phase 0
B. Phase III
C. Phase V
D. Phase II
E. Phase I (Correct Answer)
Explanation: ***Phase I***
- **Phase I clinical trials** involve a small group of healthy volunteers (typically 20-100) to primarily assess **drug safety**, determine a safe dosage range, and identify side effects.
- The main goal is to establish the **maximum tolerated dose (MTD)** and evaluate the drug's pharmacokinetic and pharmacodynamic profiles.
*Phase 0*
- **Phase 0 trials** are exploratory studies conducted in a very small number of subjects (10-15) to gather preliminary data on a drug's **pharmacodynamics and pharmacokinetics** in humans.
- They involve microdoses, not intended to have therapeutic effects, and thus cannot determine toxicity or MTD.
*Phase III*
- **Phase III trials** are large-scale studies involving hundreds to thousands of patients to confirm the drug's **efficacy**, monitor side effects, compare it to standard treatments, and collect information that will allow the drug to be used safely.
- These trials are conducted after safety and initial efficacy have been established in earlier phases.
*Phase V*
- "Phase V" is not a standard, recognized phase in the traditional clinical trial classification (Phase 0, I, II, III, IV).
- This term might be used in some non-standard research contexts or for post-marketing studies that go beyond Phase IV surveillance, but it is not a formal phase for initial drug development.
*Phase II*
- **Phase II trials** involve several hundred patients with the condition the drug is intended to treat, focusing on **drug efficacy** and further evaluating safety.
- While safety is still monitored, the primary objective shifts to determining if the drug works for its intended purpose and at what dose.
Question 5: A 65-year-old woman presents to her primary care physician for a wellness checkup. She states that she has felt well lately and has no concerns. The patient has a 12-pack-year smoking history and has 3 drinks per week. She is retired and lives at home with her husband. She had a normal colonoscopy 8 years ago and mammography 1 year ago. She can't recall when she last had a Pap smear and believes that it was when she was 62 years of age. Her temperature is 98.1°F (36.7°C), blood pressure is 137/78 mmHg, pulse is 80/min, respirations are 13/min, and oxygen saturation is 98% on room air. Physical exam is within normal limits. Which of the following is the best next step in management?
A. Colonoscopy
B. Mammogram
C. No intervention needed
D. DEXA scan (Correct Answer)
E. Pap smear
Explanation: ***DEXA scan***
- A **DEXA scan** is recommended for all women aged 65 years and older to screen for **osteoporosis**, regardless of risk factors.
- While she has several risk factors (female sex, age, smoking history), the age alone warrants screening.
*Colonoscopy*
- The patient had a normal colonoscopy 8 years ago, and routine screening for average-risk individuals typically occurs every 10 years, so it is **not yet due**.
- There are **no new symptoms** to suggest the need for an earlier repeat colonoscopy.
*Mammogram*
- The patient had a mammogram 1 year ago, and screening is typically recommended every **1 to 2 years** for women in this age group, so it is not immediately due.
- There are no new breast concerns to warrant an earlier mammogram.
*No intervention needed*
- This option is incorrect because the patient is a 65-year-old woman, placing her in a demographic for which a **DEXA scan** is routinely recommended as part of preventive care.
- While she feels well, screening interventions are designed to detect conditions before symptoms appear.
*Pap smear*
- **Cervical cancer screening** with a Pap smear can be discontinued in women over age 65 who have a history of adequate negative screening tests and are not at high risk.
- Since she had a Pap smear at 62 and has no known risk factors for cervical cancer, further screening is likely **not indicated**.
Question 6: A 78-year-old woman is brought to the emergency ward by her son for lethargy and generalized weakness. The patient speaks in short utterances and does not make eye contact with the provider or her son throughout the interview and examination. You elicit that the patient lives with her son and daughter-in-law, and she reports vague weakness for the last couple days. The emergency room provider notices 3-4 healing bruises on the patient's upper extremities; otherwise, examination is not revealing. Routine chemistries and blood counts are unremarkable; non-contrast head CT demonstrates normal age-related changes. Which of the following is the most appropriate next step in management?
A. Ask the patient's son to leave the room (Correct Answer)
B. Question the patient's son regarding the home situation
C. Call Adult Protective Services to report the patient's son
D. Perform lumbar puncture
E. Question the patient regarding abuse or neglect
Explanation: ***Ask the patient's son to leave the room***
- The patient's **lethargy**, **non-engagement**, and **healing bruises** raise strong suspicions for elder abuse or neglect. Removing the son allows for a private interview, which is crucial for her to feel safe enough to disclose information.
- In situations of suspected abuse, it is paramount to prioritize the **patient's safety and ability to speak freely** without the presence of the suspected abuser.
*Question the patient's son regarding the home situation*
- Questioning the son directly at this point may escalate the situation or make the patient even less likely to disclose abuse, as she is likely **frightened or coerced**.
- This step is premature and should only occur after a private interview with the patient, and potentially with the involvement of Protective Services.
*Call Adult Protective Services to report the patient's son*
- While reporting to **Adult Protective Services** is a critical step if abuse is confirmed, it is not the immediate first action until a private interview with the patient has been conducted to gather more information.
- Making a report without attempting to speak with the patient alone first can hinder the investigation and potentially jeopardize her safety if the abuser is alerted prematurely.
*Perform lumbar puncture*
- A lumbar puncture is an invasive procedure generally performed to diagnose **central nervous system infections** or **inflammatory conditions**.
- There are no clinical indications (e.g., fever, meningeal signs, focal neurological deficits) to suggest a need for a lumbar puncture, especially given the history and physical findings that point towards abuse.
*Question the patient regarding abuse or neglect*
- While it's important to question the patient about abuse, it must be done in a **safe and private environment** where she feels comfortable speaking freely.
- Questioning her while the suspected abuser (her son) is present would likely yield unhelpful responses due to fear or intimidation, as seen by her lack of eye contact and short utterances.
Question 7: A 59-year-old woman comes to the physician because of left leg swelling that started after a transcontinental flight. A duplex ultrasound of the left leg shows a noncompressible popliteal vein. A drug is prescribed that inhibits the coagulation cascade. Two weeks later, laboratory studies show:
Platelet count 210,000/mm3
Partial thromboplastin time 28 seconds (normal: 25-35)
Prothrombin time 12 seconds (normal: 11-13)
Thrombin time 15 seconds (control: 15 seconds)
Which of the following drugs was most likely prescribed?
A. Unfractionated heparin
B. Apixaban
C. Aspirin
D. Warfarin
E. Low molecular weight heparin (Correct Answer)
Explanation: ***Low molecular weight heparin***
- **LMWH (e.g., enoxaparin) is the first-line treatment for acute DVT** in ambulatory patients and is the most likely drug prescribed in this outpatient scenario
- LMWH enhances **antithrombin activity primarily against Factor Xa** (more than Factor IIa/thrombin), which is why it has **minimal effect on routine coagulation tests** (PT, PTT, TT)
- **Monitoring of LMWH is done via anti-Xa levels**, not PTT, PT, or TT, explaining why all these values remain normal two weeks after initiation
- The normal coagulation studies are **expected and consistent** with therapeutic LMWH use
*Unfractionated heparin*
- Unfractionated heparin (UFH) acts by enhancing **antithrombin activity against both Factor Xa and Factor IIa (thrombin)**, which significantly **prolongs PTT** (typically 1.5-2x control when therapeutic)
- UFH requires **IV administration and hospital monitoring**, making it unlikely for this ambulatory post-flight DVT patient
- If the patient were currently on UFH, the **PTT would be prolonged** (not normal as shown); if discontinued, this wouldn't be "the drug prescribed" for ongoing DVT treatment
*Apixaban*
- Apixaban is a **direct Factor Xa inhibitor** that would cause **mild prolongation of PT** and possibly PTT at therapeutic levels
- While it's a reasonable outpatient DVT treatment, the completely normal PT argues against current apixaban use
- Apixaban doesn't require routine monitoring, but when measured, coagulation times would typically show some abnormality
*Warfarin*
- Warfarin is a **vitamin K antagonist** that inhibits synthesis of factors II, VII, IX, and X, causing **significant PT/INR prolongation** (target INR 2-3 for DVT)
- The **normal PT (12 seconds) excludes warfarin** as the current medication
- Warfarin requires regular INR monitoring and would not show normal values at therapeutic doses
*Aspirin*
- Aspirin is an **antiplatelet agent** (COX-1 inhibitor) that affects platelet aggregation, **not the coagulation cascade**
- It has **no effect on PT, PTT, or TT** and is **inadequate monotherapy for DVT treatment**
- While it may have a role in extended VTE prevention, it would not be the primary drug prescribed for acute DVT
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
